BackgroundRelatively few studies have explored the differential contributions of the
accumulative dosage of psychotropic medications on mortality in patients with …

Objective: Although mortality related to psychotropic medications has received much
attention in recent years, little is known about the relationship between risk of death and …

Background: Research on antipsychotics and early mortality in schizophrenia has arisen
from Western countries and results show that mortality from natural causes is obviously …

Patients with schizophrenia have a higher mortality risk than patients suffering from any
other psychiatric disorder. Previous research is inconclusive regarding the association of …

Objective: To gather current evidence on the impact of antipsychotics on long-term mortality
in patients with schizophrenia. Methods: We systematically searched for articles in Embase …

Background It is well established that persons with schizophrenia have high mortality rates.
There is conflicting evidence that antipsychotic and perhaps other medications routinely …

BACKGROUND: Antipsychotic medication is the cornerstone of schizophrenia treatment.
The impact of long-term exposure to antipsychotics on life-expectancy has recently received …

Objective: Concomitant prescription of more than 1 antipsychotic agent (antipsychotic
polypharmacy) in the treatment of schizophrenia is prevalent, although monotherapy is …

Background: It is generally believed that long-term use of antipsychotics increases mortality
and, especially, the risk of cardiovascular death. However, there are no solid data to …

Introduction It has remained controversial if antipsychotic treatment is associated with
increased or decreased mortality among patients with schizophrenia, and if there are any …